Kaliner, Michael A <br/><br/>
Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.  [electronic resource] 

 -  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology  Jun 2003 
 - 629-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1081-1206 
<br/><br/><label>Standard No.: </label>10.1016/S1081-1206(10)61867-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Evaluation<br/>Female<br/>Histamine H1 Antagonists--administration & dosage<br/>Histamine Release--drug effects<br/>Humans<br/>Loratadine--administration & dosage<br/>Male<br/>Middle Aged<br/>Reference Values<br/>Skin Tests<br/>Terfenadine--administration & dosage<br/>Time Factors<br/>Treatment Outcome